HeartFlow, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.5M
Doctors Paid
9,758
Transactions
24,704
2024 Total
$1.9M
Payment Breakdown by Category
Research$9.2M (68.1%)
Consulting$1.9M (13.7%)
Food & Beverage$1.2M (8.7%)
Travel$296,831 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.2M | 603 | 68.1% |
| Consulting Fee | $1.9M | 647 | 13.7% |
| Food and Beverage | $1.2M | 21,859 | 8.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $787,647 | 465 | 5.8% |
| Travel and Lodging | $296,831 | 1,080 | 2.2% |
| Education | $148,750 | 24 | 1.1% |
| Space rental or facility fees (teaching hospital only) | $21,000 | 10 | 0.2% |
| Grant | $13,000 | 4 | 0.1% |
| Entertainment | $654.34 | 7 | 0.0% |
| Honoraria | $249.80 | 4 | 0.0% |
| Gift | $83.55 | 1 | 0.0% |
Payments by Type
Research
$9.2M
524 transactions
General
$4.3M
24,101 transactions
Ownership
$0
79 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care | $3.2M | 0 | 133 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE | $2.0M | 0 | 187 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 438 JACS | $890,682 | 0 | 29 |
| Prospective Randomized Trial of Optimal Evaluation of Suspected Coronary Artery Disease | $654,643 | 0 | 5 |
| RetrospectivE study of FFRCT compared to mFFR and CTA In the post-market ENvironmEnt | $356,268 | 0 | 8 |
| Precise Study | $267,144 | 0 | 32 |
| Evaluation of FFRCT to improve efficacy and efficiency of management of Patients With Acute Chest Pain as compared to anatomic CCTA and Standard of Care | $245,460 | 0 | 3 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 447 REVEALPLAQUE | $184,335 | 0 | 21 |
| REFINE Cardiovascular Imaging Core Lab. | $183,688 | 0 | 1 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 448 MGH Type 2 MI | $168,551 | 0 | 6 |
| PRECISE, C6000136 Protocol #CP-907-001-A PI: Victor Marinnescu, MD | $160,300 | 0 | 7 |
| AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management (DECIDE) | $114,550 | 0 | 17 |
| PRECISE, C6000148 Protocol #CP-907-001-A PI: Sorin Danciu, MD, | $102,250 | 0 | 1 |
| Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE) | $95,895 | 0 | 21 |
| Promise - CT - FFR Cost Effectiveness Analysis | $89,560 | 0 | 1 |
| SPECT vs CT vs. FFRCT: Diagnostic accuracy (using FFRCT as gold standard) | $78,576 | 0 | 4 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 437 P3 | $69,500 | 0 | 1 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 442 FFRct ACP | $64,800 | 0 | 2 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 443 ADVANCE-ED | $52,640 | 0 | 8 |
| "The AFFECTS Study: Assessment of Fractional Flow reservE Computed Tomography versus Single photon emission computed tomography in the diagnosis of hemodynamically significant coronary artery disease " | $46,464 | 0 | 5 |
| The AFFECTS Study: Assessment of Fractional Flow reservE Computed Tomography versus | $42,079 | 0 | 5 |
| 100 Analysis : 200 FFRct Analysis : 201 FFRct (Default) | $30,150 | 0 | 2 |
| PRECISE, C6000136 Protocol #CP-907-001-A PI: Victor Marinescu, MD, | $29,550 | 0 | 3 |
| Assessing Diagnostic Value of Non-invasive FFRCT in Coronary CarE | $12,848 | 0 | 3 |
| PRECISE CP-907-001-A - IRB FEE | $12,500 | 0 | 1 |
| Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularizaton -Protocol CP-907-001-A | $12,094 | 0 | 3 |
| PRECISE Protocol #CP-907-001-A | $11,000 | 0 | 1 |
| Precise Study -CP-907-001-A | $7,813 | 0 | 2 |
| CP-907-001-A PRECISE | $7,700 | 0 | 1 |
| PRECISE CP-907-001-A | $6,350 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 5
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Scott Williams, Md, MD | Body Imaging | Stanford, CA | $2,586 | $0 |
| Esad Vucic, M.d, M.D | Cardiovascular Disease | Newark, NJ | $2,548 | $0 |
| Dr. Steven Kindsvater, M.d, M.D | Interventional Cardiology | Keesler Afb, MS | $2,516 | $0 |
| Demetrius Dicks, M.d, M.D | Diagnostic Radiology | Marietta, GA | $2,440 | $0 |
| George Chrysant, Md, MD | Cardiovascular Disease | Oklahoma City, OK | $2,387 | $0 |
| Dr. Craig Tucker, M.d, M.D | Internal Medicine | Louisville, KY | $2,365 | $0 |
| Dr. Jeffrey Schussler, Md, MD | Interventional Cardiology | Dallas, TX | $2,344 | $0 |
| Nitesh Gadeela, M.d, M.D | Internal Medicine | Indianapolis, IN | $2,281 | $0 |
| Jonathan Morris, Md, MD | Internal Medicine | Columbia, MO | $2,250 | $0 |
| Mohit Gupta, Md, MD | Internal Medicine | Orlando, FL | $2,227 | $0 |
| Luba Frank, Md, MD | Diagnostic Radiology | Houston, TX | $2,218 | $0 |
| Michael Valentino, M.d., Ph.d, M.D., PH.D | Cardiovascular Disease | Broomall, PA | $2,203 | $0 |
| Akl Fahed, Md, MD | Cardiovascular Disease | Boston, MA | $2,200 | $0 |
| Dr. Majd Ibrahim, M.d, M.D | Cardiovascular Disease | Salt Lake Cty, UT | $2,193 | $0 |
| Roger Desprez, M.d, M.D | Specialist | Tulsa, OK | $2,163 | $0 |
| Ron Jacob, M.d, M.D | Cardiovascular Disease | York, PA | $2,128 | $0 |
| Hamid Chalian, M.d, M.D | Diagnostic Radiology | Orange, CA | $2,125 | $0 |
| Karamchand Paul, Md, MD | Cardiovascular Disease | Indianapolis, IN | $2,112 | $0 |
| Harmony Reynolds, M.d, M.D | Cardiovascular Disease | New York, NY | $2,100 | $0 |
| Jeffrey Carstens, Md, MD | Cardiovascular Disease | Omaha, NE | $2,097 | $0 |
| Fayez Raza, M.d, M.D | Internal Medicine | Dallas, TX | $2,092 | $0 |
| Dr. Andrew Ertel, M.d, M.D | Cardiovascular Disease | York, PA | $2,073 | $0 |
| Dr. Mark Peterman, Md, MD | Cardiovascular Disease | Plano, TX | $2,020 | $0 |
| Dr. Enrico Martin, M.d, M.D | Nuclear Cardiology | West Des Moines, IA | $2,010 | $0 |
| Dr. Carlos Mena-Hurtado, Md, MD | Internal Medicine | New Haven, CT | $2,000 | $0 |
About HeartFlow, Inc.
HeartFlow, Inc. has made $13.5M in payments to 9,758 healthcare providers, recorded across 24,704 transactions in the CMS Open Payments database. In 2024, the company paid $1.9M. The top product by payment volume is FFRct ($9.1M).
Payments were distributed across 126 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($2.2M to 3,323 doctors).
Payment categories include: Food & Beverage ($1.2M), Consulting ($1.9M), Research ($9.2M), Travel & Lodging ($296,831).
HeartFlow, Inc. is associated with 1 products in the CMS Open Payments database.